Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus

American Journal of Gastroenterology

Volumn 93, Issue 7, 1998, Pages 1028-1032

  Sampliner, Richard E ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS RESECTION; GASTROESOPHAGEAL REFLUX; HUMAN; INTESTINE METAPLASIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; BARRETT ESOPHAGUS; BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; SEX FACTORS;

EID: 0032467590     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00362.x     Document Type: Review

References (70)

1. 1. Naef AP, Savary M, Ozzello L, et al. Collumnar-lined lower esophagus: An acquired lesion with malignant predisposition. J Thorac Cardio Surg 1975;70:826-35.
2. 2. Spechler SJ, VA Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 1992;326:786-92.
3. 3. Haggitt RC, Tryzelaar J, Ellis FH, et al. Adenocarcinoma complicating columnar epithelium lined (Barrett's) esophagus. Am J Clin Pathol 1978;70:1-5.
4. 4. Skinner DB, Walther BC, Riddell RH, et al. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983;198:554-66.
5. 5. Smith RRL, Hamilton SR, Boitnott JK, et al. The spectrum of carcinoma arising in Barrett's esophagus. Am J Surg Pathol 1984;8:563-73.
6. 6. Rosenberg JC, Budev H, Edwards RC, et al. Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer 1985; 55:1353-60.
7. 7. Paraf F, Flejou JF, Pignon JP, et al. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 1995;19:183-91.
8. 8. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction in Barrett's esophagus. Gastroenterology 1995;109:1541-6.
9. 9. Clark GW, Smyrk TC, Budiles P, et al. Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609-14.
10. 10. MacDonald WC, MacDonald JB. Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 1987;60:1094-8.
11. 11. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-9.
12. 12. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
13. 13. Weston AP, Krmpotich P, Makdisi WF, et al. Short segment Barrett's esophagus: Clinical and histological features, associated endoscopic findings and association with gastric intestinal metaplasia. Am J Gastroenterol 1996;91:981-6.
14. 14. Johnston MH, Hammond AS, Laskin W, et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996;1:1507-11.
15. 15. Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol 1997;92:414-8.
16. 16. Spechler SJ, Zeroogian JM, Antonioli DA. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-6.
17. 17. Chalasani N, Wo JM, Hunter JG, et al. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sci 1997;42:603-7.
18. 18. DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995;155:2165-73.
19. 19. Eisen GM, Sandler RS, Murray S, et al. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 1997;92:27-31.
20. 20. Lieberman D, Oehlke M, Helfand M, GORE Consortium. Risk factors for Barrett's esophagus in community-based practice. Am J Gastroenterol 1997;92:1293-7.
21. 21. Freston JW, Malagelada JR, Petersen H, et al. Critical issues in the management of gastroesophageal reflux disease. Euro J Gastroenterol Hepatology 1995;7:577-86.
22. 22. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-5.
23. 23. Iascone C, DeMeester TR, Little AG, et al. Barrett's esophagus. Arch Surg 1983;118:543-9.
24. 24. McClave SA, Boyce HW, Gottfried MR. Early diagnosis of columnar lined esophagus: A new endoscopic criterion. Gastrointest Endosc 1987;33:413-6.
25. 25. Woolf GM, Riddell RH, Irvine EJ, et al. A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus. Gastrointest Endosc 1989;35:541-4.
26. 26. Chobanian SJ, Cattau EL, Winters C, et al. In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. Gastrointest Endosc 1987;33:99-102.
27. 27. Stevens PD, Lightdale CJ, Green PHR, et al. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointest Endosc 1994;40:747-9.
28. 28. Canto MI, Setrakian S, Petras RE, et al. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 1996;44:1-7.
29. 29. Spechler SJ, Zeroogian JM, Wang HH, et al. The frequency of specialized intestinal metaplasia at the squamocolumnar junction varies with the extent of columnar epithelium lining the esophagus. Gastroenterology 1995;180:A224.
30. 30. Zwas F. Shields HM, Doos WG, et al. Scanning electron microscopy of Barrett's epithelium and its correlation with light microscopy and mucin stains. Gastroenterology 1986;90:1932-41.
31. 31. Streitz JM, Andrews CW, Ellis FH. Endoscopie surveillance of Barrett's esophagus. J Thorac Cardiovasc Surg 1993;105:383-8.
32. 32. Peters JH, Clark GWB, Ireland AP, et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;108:813-22.
33. 33. Van der Burgh A, Dees J, Hop WCJ, et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996;39:5-8.
34. 34. Weston A, Krmpotich P, Cherian R, et al. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus. Dig Dis Sci 1997;42:597-602.
35. 35. Sharma P, Morales T, Bhattacharyya A, et al. Dysplasia in short segment Barrett's esophagus - a prospective 3 year follow-up. Am J Gastroenterol 1997;92:2012-6.
36. 36. Hamilton S, Smith R, Cameron J. Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988;19:942-8.
37. 37. Schnell T, Sontag S, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992;37:137-43.
38. 38. Riddell RH, Goldman H. Ransohoff DE, et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical information. Hum Pathol 1983;14:931-68.
39. 39. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19: 166-78.
40. 40. Salo JA, Nemlander A, Farkkila M, et al. Treatment of Barrett's metaplasia by antireflux surgery and endoscopic laser ablation: Clinical experience in ten patients. Gastroenterology 1995;108:A1243.
41. 41. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esophagus: Clinical update. Am J Gastroenterol 1996;91:1719-23.
42. 42. Sampliner RE, Fennerty MB, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results. Gastrointest Endosc 1996;44:523-5.
43. 43. Robertson CS, Mayberry IF, Nicholson DA, et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988;75:760-3.
44. 44. Hammeeteman W, Tytgat IN, Houthoff HI, et al. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989;69:1249-56.
45. 45. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's esophagus. Gut 1991;32:1441-6.
46. 46. Reid BJ, Blount PL, Rubin CE, et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212-9.
47. 47. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
48. 48. Levine DS, Haggitt RC, Irvine S, et al. Natural history of high grade dysplasia in Barrett's esophagus. Gastroenterology 1996;110:A550.
49. 43. Schnell T, Sontag SJ, Chejfec G, et al. High grade dysplasia is not an indication for surgery in patients with Barrett's esophagus. Gastroenterology 1996;110:A590.
50. 49. Edwards MJ, Gable DR, Lentsch AB, et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high grade dysplasia. Ann Surg 1996;223:585-91.
51. 50. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high grade dysplasia. Ann Surg 1996;224:66-71.
52. 51. Garewal HS, Sampliner RE, Gerner E, et al. Ornithine decarboxylase activity in Barrett's esophagus: A potential marker for dysplasia. Gastroenterology 1988;94:819-21.
53. 52. Gray MR, Hall PA, Nash J, et al. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology 1992;103:1769-76.
54. 53. Gillen P, McDermott M, Grehan D, et al. Proliferating cell nuclear antigen in the assessment of Barrett's mucosa. Br J Surg 1994;81: 1766-8.
55. 54. Hong MK, Laskin WB, Herman BE, et al. Expansion of the Ki67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995;75:423-9.
56. 55. Reid BJ, Haggitt RC, Rubin CE, et al. Barrett's esophagus: Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 1987;93:1-11.
57. 56. McKinley MJ, Budman DR, Grueneberg D, et al. DNA content in Barrett's esophagus and esophageal malignancy. Am J Gastroenterol 1987;82:1012-5.
58. 57. Fennerty MB, Sampliner RE, Way D, et al. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology 1989;97:815-20.
59. 58. Ramel S, Reid BJ, Sanchez CA, et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology 1992;102;1220-8.
60. 59. Younes M, Lebovitz RM, Lechago LV, et al. p53 Protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: A follow-up study. Gastroenterology 1993;105:1637-42.
61. 60. Neshat K, Sanchez CA, Galipeau PC, et al. p53 In Barrett's adenocarcinoma and high grade dysplasia. Gastroenterology 1994;106:1595-8.
62. 61. Jankowski J, Hopwood D, Wormsley KG. Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. Scand J Gastroenterol 1992;27: 147-54.
63. 62. Brito MJ, Filipe MI, Linehan J, et al. Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinics variables. Int J Cancer 1995;60:27-32.
64. 63. Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 1997;92:582-5.
65. 64. Stein HJ, Hoeft S, DeMeester TR. Functional foregut abnormalities in Barrett's esophagus. Thorac Cardiovasc Surg 1993;105:107-111.
66. 65. Vaezi ME, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996;111: 1192-9.
67. 66. Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994;89:989-91.
68. 67. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Gastroenterology 1990;99:918-22.
69. 68. Johnson DA, Winters C, Spurling TJ, et al. Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol 1987;9:23-27.
70. 69. Malesci A, Savarino V, Zenith P, et al. Partial regression of Barrett's esophagus by long term therapy with high dose omeprazole. Gastrointest Endosc 1996;44:700-5.